Streetbeat News

ADIA

Adia Nutrition Inc

Employees

Industry

All Other Miscellaneous Chemical Product and Preparation Manufacturing

Open

0.08

Mkt cap

7.7M

Volume

15K

High

0.08

P/E Ratio

-0.20

52-wk high

0.17

Low

0.07

Div yield

N/A

52-wk low

0.00

Adia Nutrition's subsidiary, Adia Med, will expand its treatment offerings by integrating Therapeutic Plasma Exchange (TPE) in all future full clinic locations in the US. The current location already offers TPE, alongside Hematopoietic Stem Cell Transplantation (HSCT) using advanced apheresis machines.

Portfolio Pulse from

March 17, 2025 | 12:45 pm

ADIA Nutrition Inc. is expanding its sales team to support the growth of its subsidiaries, Adia Med and Adia Labs, focusing on stem cell therapy and regenerative medicine across the U.S.

Portfolio Pulse from

March 13, 2025 | 1:15 pm

ADIA Nutrition Inc. has expanded its workforce with two strategic hires to enhance operations and elevate standards in stem cell therapy, reflecting its commitment to scaling its Adia Med division.

Portfolio Pulse from

March 11, 2025 | 2:30 pm

ADIA Nutrition Inc. is strengthening its brand by filing trademark applications for its new product 'Adia Vita' and slogan 'The Platinum Standard in Stem Cell Therapy' with the USPTO. This move aims to protect its brand from imitators and maintain its reputation in regenerative medicine.

Portfolio Pulse from

March 05, 2025 | 1:15 pm

ADIA Nutrition Inc.'s subsidiary, Adia Labs LLC, has received FDA registration for its stem cell product, Adia Vita, allowing nationwide distribution. This development is expected to enhance revenue potential by expanding access to regenerative medicine.

Portfolio Pulse from

March 03, 2025 | 1:45 pm

ADIA Nutrition Inc. has made significant advancements in February 2025, including breakthroughs in stem cell therapies, strategic partnerships, and achieving a corporate milestone. These developments follow a successful January for Adia Med, enhancing ADIA's momentum in healthcare innovation.

Portfolio Pulse from

February 28, 2025 | 3:45 pm

ADIA Nutrition Inc. is expanding its Adia Med satellite locations across the U.S. to enhance accessibility to its innovative healthcare treatments. This strategic move involves partnerships with top Medical Spas focused on anti-aging and wellness.

Portfolio Pulse from

February 24, 2025 | 3:30 pm

ADIA Nutrition Inc. has launched Adia Labs LLC, a new division focused on regenerative medicine, marking its commitment to high-quality healthcare products.

Portfolio Pulse from

February 20, 2025 | 3:15 pm

Adia Med, a division of Adia Nutrition Inc., is progressing towards registration with Florida's AHCA to accept private insurance for its stem cell therapies, potentially increasing accessibility across the US.

Portfolio Pulse from

February 13, 2025 | 1:15 pm

ADIA Nutrition Inc. has identified historical issues with share issuance, committing to retire over 25 million shares that were improperly documented.

Portfolio Pulse from

February 11, 2025 | 3:15 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.